Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06006910 · ClinicalTrials.gov registry record
Electronic Medical Record-Based Nudge to Reduce SLNB
A clinical trial of Breast Cancer and Estrogen Receptor-positive Breast Cancer, sponsored by University of Pittsburgh Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
- 1
- Study location
NCT06006910: Completed study of Breast Cancer and Estrogen Receptor-positive Breast Cancer, sponsored by University of Pittsburgh Medical Center.
NCT06006910 is a study of Breast Cancer and Estrogen Receptor-positive Breast Cancer that has completed, run by University of Pittsburgh Medical Center. The registered enrollment target is 7 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06006910, a study of Breast Cancer and Estrogen Receptor-positive Breast Cancer, has completed, sponsored by University of Pittsburgh Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective, historically-controlled, quality improvement project is to determine whether and to what extent an electronic health record (EHR)-based nudge affects rates of sentinel lymph node biopsy (SLNB) in older women with ER+, early-stage, clinically node negative breast cancer.
Primary Outcome
We will record the rate of SLNB use (yes/no for if the surgeon performed the surgery) per month over a 12 month intervention period. Rate of SLNB after nudge deployment will be compared to rate of SLNB before nudge deployment.
Conditions Studied
Interventions
- BEHAVIORAL Column-based nudge in the EHR
- BEHAVIORAL No column-based nudge in the EHR
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-10-15 |
| Est. Completion | 2024-02-12 |
What the finished NCT06006910 record still lists
NCT06006910 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Column-based nudge in the EHR is the first listed.
NCT06006910 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06006910 about?
NCT06006910 is a clinical study titled "Electronic Medical Record-Based Nudge to Reduce SLNB". The goal of this prospective, historically-controlled, quality improvement project is to determine whether and to what extent an electronic health record (EHR)-based nudge affects rates of sentinel lymph node biopsy (SLNB) in older women with ER+, early-stage, clinically node negative breast cancer.
What is the current status of trial NCT06006910?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2021-10-15. Estimated completion is 2024-02-12.
What conditions does trial NCT06006910 study?
This clinical trial studies the following conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer.
What interventions are being tested in trial NCT06006910?
The interventions under investigation include: Column-based nudge in the EHR (BEHAVIORAL), No column-based nudge in the EHR (BEHAVIORAL).
Who is sponsoring clinical trial NCT06006910?
This trial is sponsored by University of Pittsburgh Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06006910 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06006910's enrollment target sits among peer trials
7 1202nd of 1224 higher than 17 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI